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There are many similarities between the interactions of environmental protozoa with pathogenic bacterial
species and those observed in mammalian macrophages. Since single-celled protozoa predate mammalian
hosts, it is likely that interactions in environmental biofilms have selected for many of the bacterial virulence
mechanisms responsible for human disease. In order to better understand bacterial-phagocyte interactions, we
developed a selection for Acanthamoeba castellanii variants that are more resistant to killing by bacterial
pathogens. We identified four amoebal clones that display decreased phagocytosis of bacteria but no difference
in uptake of latex beads compared to wild-type amoebae. These amoebal variants display differences in cellular
morphology, partial resistance to killing by bacteria, more bactericidal activity, and higher frequencies of
lysosome fusion with the bacterial vacuole. Three proteins are present at lower levels in these variants than in
wild-type amoebae, and matrix-assisted laser desorption ionization–time of flight mass spectrometry allowed
identification of two of them as actin and hsp90. We found that specific inhibitors of hsp90 produce a similar
phenotypic effect in macrophages. These data suggest that hsp90 plays a role in phagocytic and, possibly,
bactericidal pathways that affect interactions of phagocytic cells with bacteria.
Uptake and degradation of bacterial particles are key func-
tions of phagocytes in the mammalian immune system. Phago-
cytic environmental protozoa within aquatic biofilms carry out
analogous activities in complex ecosystems that contain numer-
ous prokaryotic organisms. Recent data suggest that environ-
mental protozoa, particularly amoebae such as Acanthamoeba
castellanii, have played an important role in the evolution of
bacterial pathogens of mammals and may represent natural
hosts for virulent bacteria (4, 9). A number of different patho-
genic species, including Mycobacterium spp. (12), Vibrio chol-
erae (69), Burkholderia cepacia, Chlamydia pneumoniae, Ed-
wardsiella tarda, Legionella pneumophila (32, 59), Cryptococcus
neoformans (66), Listeria monocytogenes, and Francisella tula-
rensis (1), have the ability to survive and replicate in environ-
mental protozoa. Environmental amoebae, including A. castel-
lanii, can undergo a respiratory burst (19), produce oxygen
radicals (20), express cell surface receptors (2), and have
phagocytic mechanisms (3, 8, 39) that are similar to those of
human macrophages.
There are several important steps during the interactions of
phagocytic cells with bacterial pathogens, including adherence,
phagocytosis, signal transduction, trafficking, and intracellular
replication. It is likely that a large number of host cell compo-
nents are involved in these processes, yet few have been de-
scribed in great detail. Protozoal models for bacterial-host cell
interactions, such as the amoeba A. castellanii, should be very
useful for identification of the host cell components involved.
As opposed to that of mammalian hosts, the unicellular nature
of A. castellanii makes it possible to isolate clones for genetic
analyses. Thus, the goal of the present study was to develop
methods that would allow identification and characterization
of host cell components involved in bacterial-host cell interac-
tions in A. castellanii.
We developed a selection that would allow identification of
amoebal variants having defects in pathways necessary for op-
timal host cell infection by using L. pneumophila, an intracel-
lular pathogen that normally kills amoebae efficiently (11, 52).
A total of four A. castellanii clones were isolated that display
defects in their interactions with both mycobacteria and legio-
nellae. These variants show decreased uptake of bacteria and
enhanced bactericidal activity. Proteomic analyses suggest that
decreased levels of hsp90 are responsible for the phenotype of
the amoebal variants. In addition, pharmacological studies
confirmed that inhibition of hsp90 in murine macrophages
produces a similar phagocytic phenotype. Overall, these stud-
ies suggest, for the first time, that hsp90 is involved in phago-
cytosis of or bactericidal activity against bacteria in host cells.
MATERIALS AND METHODS
Cells and culture conditions. A. castellanii (ATCC 30234) amoebae, originally
cultured from a single amoeba (47), were grown to 90% confluency at 23°C in the
dark in 75-cm2 tissue culture flasks (Falcon) in PYG broth (12). The amoebae
were harvested before use by rapping the flask sharply to bring them into
suspension, and the number of viable cells was determined as described previ-
ously (12). The MH-S (ATCC CRL-2019) murine alveolar macrophage cell line
was maintained at 37°C and 5% CO2 in RPMI 1640 medium with 2 mM L-
glutamine (Gibco, Bethesda, Md.) supplemented with 10% heat-inactivated fetal
bovine serum (Gibco), 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g of glucose
per liter, 1.5 g of bicarbonate per liter, and 0.05 mM 2-mercaptoethanol. The
murine macrophage cell line J774A.1 (ATCC TIB67) was maintained at 37°C
and 5% CO2 in high-glucose Dulbecco’s modified Eagle medium (Mediatech
CELLGRO) supplemented with 10% heat-inactivated fetal bovine serum
(Gibco) and 2 mM L-glutamine.
Bacterial strains and growth conditions. The L. pneumophila strain used for
these studies, AA100, is a streptomycin-resistant variant (42) of L. pneumophila
serogroup 1 (23). AA100 was grown on BCYE agar (22) for 3 days at 37°C in 5%
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CO2 as described previously (10). Cultures of M. marinum strain M, a clinical
isolate obtained from the skin of a patient (55), and M. smegmatis strain mc2155
(63) were grown in Middlebrook 7H9 broth (Difco) supplemented with 0.5%
glycerol, 10% albumin-dextrose complex, and 0.25% Tween 80 at 33 and 37°C for
7 and 3 days, respectively.
Isolation of A. castellanii variants. A. castellanii was infected with L. pneumo-
phila in a 75-cm2 tissue culture flask by a standard invasion assay protocol as
described previously (11). Each flask, containing a monolayer of approximately
107 amoebae, was infected with 109 L. pneumophila amoebae for 30 min at 37°C
in high-salt (HS) buffer (43). The monolayer was then washed once with HS
buffer, 5 ml of HS buffer containing 100 g of gentamicin per ml was added, and
the mixture was incubated 2 h at 37°C, washed once with HS buffer, and incu-
bated for 4 days at 37°C in 25 ml of HS buffer. The flasks were then washed four
times with HS buffer and incubated at 24°C in the dark in 25 ml of PYG broth
plus 200 g of streptomycin per ml, 50 g of kanamycin per ml, 2 g of
polymyxin B per ml, 100 g of ampicillin per ml, 25 g of tetracycline per ml, and
25 g of chloramphenicol per ml for 20 to 30 days. During this period, the
monolayers were washed with HS buffer and fresh PYG broth plus antibiotic was
added every 5 to 7 days. After this incubation, clones were isolated by limiting
dilution (31). The first four rounds of selection were carried out with a single
flask, whereas subsequent rounds of selection were done by splitting the output
from round 4 into a total of 10 different flasks that were enriched for L. pneu-
mophila-resistant variants independently. A total of 12 successive rounds of
selection (4 as a single pool plus 8 independent rounds) were carried out in this
manner, and clones were isolated from each round by limiting dilution and
characterized for resistance to L. pneumophila infection. Each of the individual
clones further characterized in this study was cloned by limiting dilution from a
different flask after the final round of selection. The stability of each clone was
tested by continuous passage in PYG broth for 6 months, followed by reevalu-
ation of the frequencies of Legionella phagocytosis.
Phagocytosis assays. Phagocytosis assays were carried out in 24-well tissue
culture dishes (Falcon) (10, 14). A. castellanii was seeded into the dishes at 1.5 
105/well, allowed to adhere overnight at 23°C, washed once with HS buffer, and
incubated in 1 ml of HS buffer for 1 h at 37°C, and 3  106 bacteria were added.
After coincubation with the bacteria for 30 min, the amoebae were washed twice
with HS buffer and incubated in HS buffer plus 100 g of gentamicin per ml
(legionellae) or 200 g of amikacin per ml (mycobacteria) for 2 h at 37°C. The
amoeba were then lysed by incubation for 10 min in 1 ml of sterile water,
followed by vigorous pipetting. Dilutions were then plated on the appropriate
medium to determine CFU counts.
We also used fluorescein isothiocyanate-conjugated latex beads (Molecular
Probes, Eugene, Oreg.) and bacteria labeled with Oregon Green 418 (Molecular
Probes) as described previously (13) to evaluate the phagocytic phenotype of the
amoebal variants and macrophages treated with cellular inhibitors. In these
assays, the cells were seeded in eight-well Permanox chamber slides (Nunc) at a
density of 104/well and latex beads (1 m; Molecular Probes) or fluorescent
bacteria were added at a ratio of 20 per cell. After 30 min of coincubation,
unbound beads or bacteria were removed by extensive washing with HS buffer.
The cells were fixed in 4% paraformaldehyde in PBS buffer and mounted in 50%
glycerol. The slides were examined under a Nikon TE300 fluorescence micro-
scope with a fluorescein isothiocyanate filter. The percentage of cells that con-
tained latex beads or bacteria and the number of beads or bacteria per cell were
then determined by visual counts of 150 cells in random fields for each sample.
Assays for amoebal growth and killing by L. pneumophila. The ability of the A.
castellanii variants to be killed by L. pneumophila was evaluated by measuring the
viability of the amoebae after infection with the bacteria over time. The amoebae
were infected with L. pneumophila in the same manner as described for phago-
cytosis assays. After gentamicin treatment, the amoebae were washed with HS
buffer and incubated in HS buffer for 12 h prior to the initial determination of
amoebal viability. Viability of amoebae was determined as described previously
(12) at various time points. Basically, the amoebae were brought into suspension
by pipetting, aliquots were stained with eosin Y (Sigma), and viable amoebae
were counted with a hemacytometer (Hausser Scientific). Amoebal growth rates
were determined in a similar manner but with incubation in standard PYG
growth medium for 10 days and no bacterial infection.
Bactericidal activity of amoebal variants. Intracellular survival assays were
carried out as described previously (12). L. pneumophila was added to a mono-
layer of 1.5  105 amoebae in 24-well tissue culture dishes at a multiplicity of
infection (MOI) of 20 and incubated at 37°C for 30 min; the cells were washed
three times with HS buffer and lysed at various time points with water. Survival
is expressed as the percentage of CFU present at each time point compared to
the number present at time zero (30 min), i.e., % survival  (CFU at Tx/CFU at
T0)  100.
Amoebal morphology and lysosomal fusion frequencies. Light microscopy was
carried out with live amoebae seeded at 37°C into a temperature-controlled
closed perfusion chamber (Brook Industries) on a Nikon TE300 inverted micro-
scope with differential-interference-contrast (DIC) optics.
Lysosomes were stained, and the frequency of fusion with the bacterial phago-
some was determined by transmission electron microscopy essentially as de-
scribed previously (12). After the amoebae were prelabeled with thorium dioxide
(Polysciences), they were infected with L. pneumophila for 30 min. These sam-
ples and parallel unlabeled, uninfected amoeba samples for morphology studies
were then fixed and prepared for electron microscopy as described previously (6,
12, 49).
Proteomic analysis. Amoebae were grown to log phase, and 2  107 cells were
collected by centrifugation at 100  g for 10 min. The pellets were washed twice
with cold phosphate-buffered saline (PBS) and resuspended in 500 l of lysis
buffer (10 mM HEPES, 200 mM NaCl, 2 mM CaCl2, 2.5 mM MgCl2, 1% Triton
X-100, 1 mM phenylmethylsulfonyl fluoride, 1 protease inhibitor cocktail). The
suspension was incubated on ice for 30 min and sonicated for 10 s. The lysate was
centrifuged at 5,000  g at 4°C for 20 min to remove debris, and the supernatant
was taken as the total protein sample. The concentration of protein was deter-
mined with the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, Calif.).
Six hundred micrograms of protein from both wild-type and variant amoebae was
then subjected to two-dimensional gel electrophoresis. The first isoelectric fo-
cusing (IEF) dimension was performed with immobilized pH gradient gel strips
(17 cm, pH 3 to 10, nonlinear; Bio-Rad) and a Bio-Rad IEF cell. The strips were
rehydrated with the protein samples in rehydration buffer {7 M urea, 2 M
thiourea, 100 mM dithiothreitol (DTT), 4% (wt/vol) 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate (CHAPS), 0.001% bromophenol blue,
0.2% Bio-Lytes} at 50 V for 12 h in the IEF cell and focused at 10,000 V for a
total of 80,000 V  h. Before being loaded on the second dimension, focused
immobilized pH gradient strips were equilibrated in buffer I, which contained 6
M urea, 2% sodium dodecyl sulfate, 0.375 M Tris-HCl (pH 8.8), 20% glycerol,
and 130 mM DTT, for 15 min and then in equilibration buffer II, in which DTT
was replaced with 135 mM iodoacetamide, for another 15 min. The second-
dimension electrophoresis was performed with a Bio-Rad Protein II xi apparatus
on 10% acrylamide gels. After electrophoresis, the proteins were stained with
Coomassie G-250 (Sigma, St. Louis, Mo.). Gel images were captured with a
ProImage Analyzer camera and analyzed with Image Analyzer HD software
(Genomic Solutions). To identify differences, all spots were compared to at least
five reference spots that were consistently similar and well separated in all gels
and quadruplicate pairs of independently prepared samples were used for each
variant and wild-type amoebae.
MALDI-TOF mass spectrometry. For matrix-assisted laser desorption ioniza-
tion–time of flight (MALDI-TOF) mass spectrometry, protein spots of interest
were excised from the gel, washed, and analyzed as described previously (28). In
brief, gel pieces were washed in 25 mM ammonium bicarbonate (NH4HCO3),
pH 8.0, for 30 min, in 50% acetonitrile–25 mM NH4HCO3 for another 30 min,
and finally with ultrapure water before complete dehydration in a vacuum cen-
trifuge. The gel pieces were rehydrated with a minimum amount of sequence
grade modified porcine trypsin solution containing 0.25 to 0.5 g of protease,
depending on the amount of protein. Digestion was performed at 37°C for 3 to
5 h. Mass spectra of the tryptic digests were acquired on a MALDI-TOF mass
spectrometer operating in the reflector mode. A 0.5-ml volume of each digest
solution (in 25 mM NH4CO3–10% acetonitrile) was deposited directly onto the
sample probe on a dry thin layer of matrix made of -cyano-4-hydroxy-trans-
cinnamic acid mixed with nitrocellulose (4:3 [vol/vol] mixture of a saturated
solution of -cyano-4-hydroxy-trans-cinnamic acid in acetone and a solution
consisting of 5 mg of nitrocellulose dissolved in 1 ml of isopropanol-acetone [1:1,
vol/vol]). Deposits were washed with 5 ml of 0.1% trifluoroacetic acid before
analysis. The peptide mass fingerprint obtained from each protein digested was
analyzed with Mascot software (Matrix Science, London, United Kingdom) for
protein identification.
Immunoprecipitation and Western analysis. The same number of cells from
wild-type amoeba and the variants were collected and washed once with cold
PBS, and cell lysates were prepared as described above. The cell lysates were
immunoprecipitated with 10 g of monoclonal antibody against hsp90 (Stress-
Gen Biotechnologies, Victoria, Canada) or -tubulin (Sigma) while shaking at
4°C overnight. The immunocomplex was then incubated with protein G-Sepha-
rose (Amersham) for 2 h, washed with lysis buffer four times, and fractionated by
10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The proteins
were then transferred to a nitrocellulose membrane (Poll) with a Bio-Rad trans-
fer apparatus in accordance with the manufacturer’s protocols. After incubation
with 5% nonfat milk in TTBS (0.05% Tween 20, 20 mM Tris-HCl, pH 7.4) for 60
min, the membrane was washed once with TTBS and incubated with mouse
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monoclonal antibodies (1:1,000) directed against hsp90 or -tubulin at room
temperature for 1 h. Membranes were washed three times for 10 min and
incubated with a 1:3,000 dilution of horseradish peroxidase-conjugated anti-
mouse immunoglobulin G (Sigma) for 1 h and detected with the ECL system
(Amersham Pharmacia, Piscataway, N.J.). Densitometric analysis was carried out
with ImageQuant software (Molecular Dynamics).
Pharmacological inhibitors of hsp90. The hsp90 inhibitors used in this study,
geldanamycin (GA), radicicol (RD), herbimycin A (HB), and novobiocin (NB),
were purchased from Sigma. After pretreatment of MH-S murine alveolar mac-
rophages with each of the inhibitors at various concentrations, phagocytosis
assays were performed in the same manner as described for amoebae, except that
the cells were maintained in RPMI medium and washed with PBS. Intracellular
survival assays were carried out with MH-S cells that had been either pretreated
with the inhibitors and removed before addition of the bacteria or left in the
medium throughout the entire experiment (24 h). For these assays, the cells were
infected with bacteria in the same manner as for assays of survival in amoebae.
The viability of the cells after treatment with these inhibitors and their solvents
was determined with eosin Y and counting in a hemacytometer as described
previously (12).
Quantitation of mitochondria in macrophages. The effects of hsp90 inhibitors
on the number of mitochondria in MH-S murine alveolar macrophages was
determined with a fluorescence-activated cell sorter. MH-S cells were treated
with each inhibitor for 48 h, the cells were incubated with MitoTracker (Molec-
ular Probes) at 20 mM for 30 min, excess dye was washed away, and at least
10,000 cells were analyzed for each sample on a Becton Dickinson FACScan flow
cytometer.
Statistical analyses. Data presented are the means and standard deviations of
triplicate samples from a representative experiment. All experiments were re-
peated at least three times, unless otherwise noted. Significance was determined
by analysis of variance. P values of 0.05 were considered significant.
RESULTS
Isolation of stable A. castellanii variants. In order to better
understand the host side of bacterium-host cell interactions,
we took advantage of the single-celled nature of the environ-
mental amoeba A. castellanii. When A. castellanii is infected
with L. pneumophila at an MOI of 100 for 4 days, the entire
monolayer of 107 amoebae is completely destroyed (11).
Considering this information, it might be possible to use the
amoebicidal activity of L. pneumophila as a direct selection for
amoebae that have acquired changes in host cell components
that play a role during interactions with bacteria. To test this
hypothesis, we infected amoebae under conditions in which
they would be almost entirely killed by L. pneumophila and
grew those amoebae that survived this treatment. We carried
out multiple infections in this manner for up to 12 rounds of
selection. Individual amoebae were cloned from each round of
selection by limiting dilution. Clones from the first through the
fourth rounds were evaluated by comparing their frequencies
of phagocytosis of L. pneumophila to that of wild-type amoe-
bae. No significant differences were observed between the wild
type and clones from these early rounds of selection (data not
shown). However, four clones from the 12th round of selec-
tion, designated Ac3R, Ac4R, Ac6R, and Ac9R, were identi-
fied that displayed a decreased level of bacterial phagocytosis
(P  0.025; Fig. 1A). Although these data are for a ratio of
bacteria per amoeba (MOI) of 20, we tested multiple MOIs
ranging from 20 to 1 and all MOIs displayed the same level of
decreased phagocytosis (data not shown). We examined the
stability of the variants by continuous passage in the laboratory
for more than 6 months, followed by reexamination of the
phagocytic phenotype (Fig. 1A). These variants displayed a
stable phagocytic phenotype after continuous laboratory pas-
sage. In addition, none of the variants grew at a rate different
from that of wild-type amoebae (P  0.1) in standard PYG
laboratory medium (data not shown).
Amoebal variants are defective in phagocytosis of mycobac-
teria. We examined the specificity of the phagocytic defect with
FIG. 1. Phagocytosis of L. pneumophila (A) or M. smegmatis and
M. marinum (B) by A. castellanii (Ac) variants calculated as the per-
centage of that displayed by wild-type amoebae (AcWT) under the
same conditions. Phagocytosis assays were carried out by coincubating
the bacteria with cells for 30 min and evaluating the number of bac-
terial CFU that are intracellular at the end of this time period. Amoe-
bal variants (Ac3R, Ac4R, Ac6R, and Ac9R) were characterized for L.
pneumophila phagocytosis immediately after cloning by limiting dilu-
tion and after passage during continuous culture for 6 months. The
data points and error bars represent the means and standard devia-
tions, respectively, of assays done in triplicate. The data shown are
representative of at least three independent experiments.
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mycobacteria as phagocytic particles. We chose both patho-
genic and nonpathogenic mycobacterial species, Mycobacte-
rium marinum and Mycobacterium smegmatis, respectively, for
these studies. The amoebal variants were defective for phago-
cytosis of both M. smegmatis and M. marinum at levels similar
to that observed for L. pneumophila (Fig. 1B). These observa-
tions suggest that the defect present in these amoebae is rel-
atively broad and likely to affect a number of bacterial species,
since mycobacteria (gram positive) and legionellae (gram neg-
ative) are very distantly related.
Amoebal variants are morphologically different from the
wild type. To further characterize these amoebal variants, we
examined their morphology by light and electron microscopy.
Light microscopy demonstrated that the variants contain fewer
intracellular vacuoles and have a more rounded shape than
wild-type amoebae (Fig. 2). Electron microscopy confirmed
the relative paucity of intracellular vacuoles in the variants and
suggested that the number of mitochondria is greater in the
variants than in the wild type (Fig. 2). We quantitated the
number of vacuoles and mitochondria in both the variants and
the wild type. The number of intracellular vacuoles is signifi-
cantly lower in all variants than in the wild type, and the
number of mitochondria is significantly higher in Ac3R and
Ac9R (Table 1). The morphological differences observed are
stable over 6 months of passage in the laboratory. These ob-
servations suggest that the amoebal variants carry differences
that affect more than one cellular characteristic and, as a re-
sult, might affect all phagocytic events.
Amoebal variants are not defective for phagocytosis of latex
beads. To test whether the phagocytic defect is due to a general
cellular defect, rather than specific to bacterial uptake, we
examined the ability of these amoebae to take up latex beads.
Although all of the amoebal variants displayed reduced uptake
of fluorescent bacteria by microscopy, both the number of
beads per cell and the percentage of cells that phagocytosed at
least one bead were the same for all mutants as for wild-type
amoebae (Table 2). Although the mean values for variant
Ac9R appear somewhat lower than for the wild type, this
difference is not significant (P  0.2). These observations sug-
FIG. 2. Morphology of wild-type A. castellanii (A, B, G, H) and amoebal variants Ac3R (C, I), Ac4R (E, K), Ac6R (D, J), and Ac9R (F, L)
by DIC microscopy (A to F) and transmission electron microscopy (G to L). The A. castellanii nucleus (N) and contractile vacuole (V) are visible
in each DIC panel. The bar in each DIC panel is 10 m. The bar in panel G is 1 m and applies to panels G to L. Electron-dense particles in
panels G to L are mostly mitochondria with a single nucleus and nucleolus visible. Electron-transparent regions are vacuolar compartments with
the contractile vacuole commonly appearing as the largest vacuole.





Wild type 7.8 	 2.5 9.2 	 2.7
Ac3R 4.5 	 1.9b 12 	 4.3b
Ac4R 4.4 	 2.2b 11 	 3.5
Ac6R 4.1 	 2.2b 11 	 5.3
Ac9R 4.5 	 2.1b 15 	 4.4b
6-mo wild type 6.1 	 1.5 9.3 	 2.6
6-mo Ac3R 4.2 	 1.2b 14.4 	 3.3b
6-mo Ac4R 4.8 	 1.2b 11.4 	 2.7
6-mo Ac6R 5.1 	 1.5b 12.0 	 3.1
6-mo Ac9R 4.8 	 1.4b 14.8 	 2.9b
a Number of food vacuoles (excluding contractile vacuole) per amoeba in two
counts of 50 cells each from amoebal variants and the wild type immediately after
isolation and following passage in the laboratory for 6 months. The results are
the means 	 standard deviations. The data are representative of at least two
independent experiments.
b Significantly different (P  0.05) from the result for wild-type A. castellanii.
TABLE 2. Phagocytosis of latex beads and bacteria by amoebae
Amoebae
% Phagocytosisa No. of particles/amoeba
Beads Bacteria Beads Bacteria
Wild type 90 	 16 71 	 5.3 3.4 	 2.5 3.2 	 0.1
Ac3R 92 	 15 37 	 3.1b 2.9 	 2.1 2.0 	 0.1b
Ac4R 91 	 17 37 	 9.4b 3.4 	 2.4 3.0 	 0.2
Ac6R 91 	 19 53 	 9.8b 3.4 	 2.3 2.7 	 0.2b
Ac9R 78 	 19 55 	 10b 2.2 	 1.6 2.7 	 0.2b
a Percentage of amoebae that contained at least one bacterium (L. pneumo-
phila) or bead as determined by fluorescence microscopy. The results are the
means 	 standard deviations for three counts of 50 amoebae. The data are
representative of at least two independent experiments.
b Significantly different (P  0.05) from the result for wild-type A. castellanii.
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gest that the phagocytic phenotype of these variants is at least
somewhat specific to their interactions with bacteria, rather
than affecting uptake of all phagocytic particles, and is not
solely the result of rapid intracellular killing, since enumera-
tion of fluorescent bacterial particles phagocytosed is not de-
pendent on bacterial viability.
Amoebal variants are resistant to killing by L. pneumophila.
We infected each of the amoebal variants with L. pneumophila
for 30 min and compared their subsequent viability over time
(Fig. 3). All of the amoebal variants were more resistant to
killing by L. pneumophila than were wild-type amoebae (P 
0.01). Thus, these variants display an L. pneumophila-resistant
phenotype, possibly resulting from decreased uptake of the
bacteria or increased bactericidal activity.
Amoebal variants display enhanced bactericidal activity.
We monitored the intracellular survival of L. pneumophila in
wild-type amoebae and the variants over time. All amoebal
variants displayed higher (P  0.01) bactericidal activity than
did wild-type amoebae (Fig. 4). Normally, by 10 h after infec-
tion at least some bacterial replication is observable in wild-
type amoebae, but replication is not observed with each of the
variants until later and the bacteria are killed at higher levels
early during infection. In order to determine whether the lower
levels of phagocytosis leading to fewer intracellular bacteria is
the reason for the increased ability of the amoebae to kill
them, we tested survival and replication at a lower MOI than
20 bacteria per amoeba, which is the standard condition, in
wild-type amoebae (Fig. 4). On the basis of these data, there is
no correlation between the numbers of bacteria phagocytosed
and their ability to survive and replicate in wild-type amoebae.
FIG. 3. Percent viability of the A. castellanii wild type (AcWT) and
variant clones Ac3R, Ac4R, Ac6R, and Ac9R after infection with L.
pneumophila. For viability studies, the amoebae were first infected with
bacteria in the same manner as for phagocytosis assays, followed by
removal of extracellular bacteria and determination of amoebal via-
bility at various time points. Time zero is 12 h after addition of bac-
teria. The viability of each amoeba was arbitrarily set to 100% at the
first time point. Data points and error bars represent the means and
standard deviations, respectively, of assays done in triplicate. The data
shown are representative of at least three independent experiments.
FIG. 4. Survival of L. pneumophila in wild-type (AcWT) A. castel-
lanii and amoebal variants Ac3R and Ac4R (A) or Ac6R and Ac9R
(B) and in wild-type amoebae when different MOIs were used on the
basis of the ratio of the number of bacteria available for phagocytosis
per amoeba (C). Amoebae were infected in the same manner as for
phagocytosis assays, and the number of intracellular bacterial CFU was
determined at various time points (Tx) relative to time zero (T0, 30
min). Data points and error bars represent the means and standard
deviations, respectively, of assays done in triplicate. The data shown
are representative of at least three independent experiments.
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These observations suggest that there are differences in how
the amoebal variants interact with bacteria at early time points
during signal transduction, phagocytosis, and/or trafficking.
Amoebal variants circumvent inhibition of lysosomal fusion
by L. pneumophila. Inhibition of lysosomal fusion by L. pneu-
mophila is a key factor in their ability to survive and replicate
in macrophages (33) and amoebae (7). Since we observed a
decrease in the ability of L. pneumophila to survive in the
amoebal variants, differences in trafficking of the bacterial
phagosome may be at least partially responsible. We investi-
gated this possibility by transmission electron microscopy with
thorium dioxide as a marker for the lysosomal compartment
(Fig. 5). The frequency of lysosomal fusion with the L. pneu-
mophila vacuole in the variants was significantly higher (P 
0.02) than for wild-type A. castellanii (Table 3). These data
suggest that one of the factors involved in the enhanced bac-
tericidal activity of the amoebal variants is a decreased ability
of L. pneumophila to inhibit phagosome-lysosome fusion in
these cells.
Amoebal variants have a limited number of protein differ-
ences. Since the amoebal variants differ from the wild type in
a number of phenotypic characteristics, we carried out pro-
teomic analysis to identify any molecular differences from wild-
type amoebae. Analysis of total proteins from the variants
resulted in the identification of three to six proteins that are
absent and three to four that are at lower levels in each of the
variants compared to wild-type amoebae. Although all of these
differences were consistent over four sets of gels run in parallel,
three proteins were consistently at lower levels or absent in all
four of these variants (Fig. 6). These observations suggest that
some or all of these three proteins are important for the phe-
notypic characteristics of the amoebal variants.
Hsp90 is down-regulated in all of the amoebal variants.
Each of these spots was excised and subjected to MALDI-TOF
mass spectrometry in order to determine the identity of the
protein that it represents. Two of these spots matched, at very
high significance, actin and hsp90, and the third spot displayed
FIG. 5. Transmission electron micrographs of L. pneumophila vacuoles that have not fused (A) and that have fused (B to F) with lysosomes
in thorium dioxide-labeled wild-type A. castellanii (A, D) and clones Ac3R (B), Ac4R (C), Ac6R (E), and Ac9R (F) at 30 min postinfection.
Granular, electron-dense material is thorium dioxide that has accumulated in lysosomes. After the amoebae were prelabeled with thorium dioxide
and the excess label was removed, the amoebae were infected with bacteria in the same manner as for phagocytosis assays prior to fixation at
various time points and preparation for electron microscopy. When thorium dioxide is present in the same intracellular compartment with bacteria,
they are considered to have fused with lysosomes. The bar in the bottom left of panel D is 1 m and applies to all of the panels. Arrows indicate
bacteria in each panel.
TABLE 3. Fusion of L. pneumophila vacuoles with lysosomes
Amoebae
% Fusiona
30 min 120 min
Wild type 31 	 5 46 	 6
Ac3R 57 	 2b 64 	 4b
Ac4R 63 	 7b 68 	 6b
Ac6R 51 	 2b 72 	 3b
Ac9R 55 	 1b 62 	 5b
a Percentage of bacterial (L. pneumophila) vacuoles containing thorium. The
results are the means 	 standard deviations for three counts of 50 amoebae in
different sections of the same preparation. The data are representative of at least
two independent experiments.
b Significantly different (P  0.02) from the result for wild-type A. castellanii.
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some similarity to cyclophilin D but did not reach significance
(Table 4). The presence of low levels of hsp90 in the amoebal
variants was confirmed by Western analysis of proteins immu-
noprecipitated with an anti-hsp90 monoclonal antibody (Fig.
7). Identical volumes of the same amoebal lysate were also
immunoprecipitated with -tubulin monoclonal antibody as a
control for protein loading differences. Densitometric analysis
of the relative levels of hsp90 compared to -tubulin demon-
strated that all amoebal variants have between 5- and 20-fold
lower levels of hsp90 than the wild type.
Inhibition of hsp90 in macrophages increases mitochon-
drial numbers and bacterial phagocytosis and survival. Since
hsp90 is thought to interact with both actin (36, 48) and cyclo-
philins (68, 72), as well as a number of other cellular proteins
(53), it is possible that this protein is a key factor in the
phenotypic characteristics of the variants. A number of specific
inhibitors exist for hsp90 in mammalian cells, allowing us to
test whether this protein plays a role in phagocytosis of bacte-
ria. However, since none of these inhibitors produced the ex-
pected effects in amoebae (data not shown), we conducted
inhibitor studies with mammalian cells. These inhibitors pro-
duced similar results with both J774A.1 (data not shown) and
MH-S murine macrophage cell lines. We found that all inhib-
itors of hsp90 significantly increased fluorescent staining with
the mitochondrion-specific dye MitoTracker (Table 5). In ad-
dition, these inhibitors decreased phagocytosis of L. pneumo-
phila in a dose-dependent manner whether viable intracellular
bacteria or microscopy was used to determine the number of
particles phagocytosed, yet the inhibitors did not reduce the
phagocytosis of latex beads (Fig. 8A). Furthermore, intracel-
lular survival and replication of L. pneumophila were reduced
in macrophages pretreated with hsp90 inhibitors prior to in-
fection (Fig. 8B). To ensure that the inhibitors did not directly
inhibit the growth of the bacteria, we examined survival and
replication of L. pneumophila when the inhibitors were present
during bacterial interactions with macrophages. Most of the
inhibitors, with the exception of NB, produced similarly re-
duced levels of L. pneumophila survival and replication either
when they were used to pretreat the cells or when they were
present throughout the experiment (Fig. 8B). When NB was
present throughout the experiment, no bacterial replication
was observed, suggesting that this inhibitor affects bacterial
FIG. 6. Proteomic analysis of differences between wild-type (AcWT) and variant amoebae. Example of a single Coomassie-stained two-
dimensional polyacrylamide gel electrophoresis gel of total proteins from amoebal variant Ac3R (A) and comparative analysis (B) of spots 55, 280,
and 434, which were found in all variants at lower levels than in the wild type. During this analysis, all spots on each gel were compared to a
minimum of five reference spots that were consistently present and clearly separated in all gels. Once differences were found, they were reexamined
in a minimum of three independent experiments and quadruplicate pairs of gels to evaluate whether the differences were consistent.
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replication and pretreatment of the macrophages may have
some degree of inhibitory effect on the bacteria themselves.
None of these inhibitors or their solvents, at the concentrations
and time points used, affected macrophage or bacterial viabil-
ity (data not shown). These observations support a role for
hsp90 in cellular pathways that are important for uptake and/or
killing of bacteria in phagocytic cells.
DISCUSSION
Our selection strategy has allowed the isolation of four A.
castellanii variants that display lower levels of bacterial phago-
cytosis than wild-type amoebae. Potential mechanisms that
might lead to this phenotype include loss or alteration of a
receptor, modification of signaling pathways, cytoskeletal
changes affecting phagocytosis, and increased bactericidal ac-
tivity. Each of these clones displays differences in multiple
stages during its interactions with bacteria. However, through
the use of two-dimensional polyacrylamide gel electrophoresis
we were able to evaluate differences in the protein profiles of
these clones and identify those that differ from wild-type amoe-
bae. On the basis of our data, hsp90 appears to be important
for the observed phenotypic traits of these variants. hsp90 is
very conserved across species and is an essential stress protein
in eukaryotic cells (38, 74). Since hsp90 has truly pleiotropic
activities (53), it is possible that lower levels of this single
protein are responsible for all of the differences between these
variants and wild-type amoebae.
Although these are the first A. castellanii variants identified
that affect interactions with L. pneumophila, another model
FIG. 7. Levels of hsp90 or -tubulin in wild-type (AcWT) and
variant (Ac3R and Ac4R) amoebae as determined by Western analysis
of identical volumes of the same amoebal lysate immunoprecipitated
with anti-hsp90 or -tubulin monoclonal antibody (A) and densitomet-
ric analysis of the levels of hsp90 calculated relative to the -tubulin
present in each amoebal lysate (B). The data shown are representative
of at least three independent experiments.
TABLE 4. MALDI-TOF analysis of differentially expressed proteins
Spot no. Gene




55 gi:1708316 85 80 8 242 ELISNASDALDK
hsp90 HFSVEGQLEFK
GIVDSEDLPLNISR
280 gi:5739196 20 19 3 15 QGNTPLGR
Cyclophilin D IGCLSMANAGK








a Number of peptides that matched by Mascot (www.matrixscience.com) on the spectra obtained from each protein spot.
b Scores of 23 are considered significant (P  0.05).
c Amino acid sequences of unique peptide matches.
TABLE 5. Mitochondria in macrophages treated with
hsp90 inhibitors
Treatment Mitochondrialfluorescencea
Medium.................................................................................... 67.7 	 0.7
500 nM RD ............................................................................. 80.4 	 1.6b
500 nM GA .............................................................................101.2 	 3.8b
1 mM NB................................................................................. 83.0 	 2.5b
1 M HB .................................................................................114.1 	 0.0b
a Mean fluorescence 	 standard deviation of 10,000 cells as measured by flow
cytometry after staining of hsp90 inhibitor-treated MH-S murine alveolar mac-
rophages with the mitochondrion-specific fluorescent marker MitoTracker. The
data are representative of at least two independent experiments. The inhibitors
used were RD, GA, NB and HB.
b Significantly different (P  0.01) from the result for medium.
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system for L. pneumophila host-pathogen interactions has been
used for analysis of host factors involved, i.e., Dictyostelium
discoideum (30, 64). Interestingly, most of the D. discoideum
mutants examined that were considered good candidates for
playing a role in host-pathogen interactions increased rather
than decreased the susceptibility of D. discoideum. Only a GB
mutant, which is defective for all types of trimeric G-protein
signaling, displayed a slightly reduced ability to support growth
of L. pneumophila (64). Thus, the current strategy of enriching
for bacterium-resistant variants has allowed the identification
of a second host factor involved in host cell-L. pneumophila
interactions without the cumbersome task of screening a large
number of mutants with changes in candidate genes of interest.
Possibly, the enrichment method developed in the present
study could be applied to D. discoideum or pools of D. discoi-
deum mutants. Certainly, this procedure could be improved by
conducting mutagenesis of the amoebae, to increase the fre-
quency at which variants would be found, and enriching for
variants from a number of independent pools, to prevent the
isolation of siblings, which was most likely responsible for our
observation that all variants displayed decreased levels of
hsp90. One limitation of this approach with D. discoideum is
that L. pneumophila does not infect and kill D. discoideum (30,
64) as efficiently as it does A. castellanii. Furthermore, although
D. discoideum has many similarities to other environmental
protozoa, there is no evidence that it can serve as a natural host
for L. pneumophila, possibly because D. discoideum prefers soil
habitats (5) and L. pneumophila prefers aquatic environments
(24, 25). Thus, the fact that A. castellanii is a natural host for L.
pneumophila may prove to be a valuable asset for further
analysis of host-pathogen interactions.
The A. castellanii variants we have isolated display decreased
vacuolation, and two of them have an increased number of
mitochondria. Previous observations of macrophages suggest
that an increased number of mitochondria correlate with acti-
vation of macrophages (15, 16) and greater resistance to in-
fection (35). In macrophages, resistance to infection may result
from an enhanced ability to carry out oxidative phosphoryla-
tion during a respiratory burst (50). A respiratory burst results
in secretion of extracellular ATP (61, 70), which is known to
increase the production of reactive oxygen and nitrogen spe-
cies (44, 61, 70). Interestingly, a role for hsp90 in control of
superoxide production in host cells has recently been suggested
(65). Further characterization of these variants may provide
FIG. 8. Phagocytosis of L. pneumophila (Bacteria) or 1-m latex
beads (Beads) by MH-S murine alveolar macrophages (A) and survival
and replication of L. pneumophila over 24 h within these same cells
(B). Assays were carried out in the presence and absence (Medium) of
various concentrations of specific hsp90 inhibitors. Phagocytosis assays
for bacteria [Bacteria (cfu)] were carried out in the same manner as
described for amoebae and by evaluating the number of bacterial CFU
that were intracellular at the end of this time period. Phagocytosis of
bacteria [Bacteria (microscopy)] and beads [Beads (microscopy)] was
quantitated by fluorescence microscopy to determine the percentage of
cells that contained at least one particle for three counts of 50 amoe-
bae. Survival and replication assays were carried out by first pretreat-
ing the cells with the inhibitor and either removing it by washing prior
to infection (Pretreatment with inhibitor) or pretreatment followed by
infection and maintenance of the presence of the inhibitor throughout
the remainder of the experiment (Survival in presence inhibitor). Sur-
vival and replication were evaluated at 24 h postinfection (T24) relative
to time zero (T0, 30 min). The inhibitors used were RD, GA, NB, and
HB. Phagocytosis was calculated as the percentage of that displayed in
the absence of any inhibitor. Data points and error bars represent the
means and standard deviations, respectively, of assays done in tripli-
cate. The data shown are representative of at least three independent
experiments.
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insight into the role of hsp90 in bactericidal mechanisms, sim-
ilar to those found in mammalian macrophages.
Signaling events that affect intracellular trafficking and bac-
tericidal activity may be triggered by bacteria binding to dif-
ferent host cell receptors. hsp90 is known to interact with a
number of different cell surface receptors, including scavenger
receptors (45) and steroid receptors (21). It has also been
suggested that hsp90 itself can serve as a receptor for either
lipopolysaccharide (71) or specific bacterial proteins (34). In
addition, hsp90 plays an important role in a number of recep-
tor-mediated signal transduction pathways (53, 57). This con-
cept fits well with the observation that phagocytosis of latex
beads is triggered by mechanical contact rather than a recep-
tor-mediated pathway (73). Effects on receptors or signal
transduction may be responsible for the bactericidal pheno-
type, but it is possible that trafficking of the bacterial vacuole is
affected directly considering that hsp90 can play an important
role in receptor trafficking (18, 27). Further analysis of these
variants should allow us to differentiate between these possi-
bilities.
Although all of the variants display lower levels of hsp90,
they show slightly different phenotypic characteristics and have
lower levels of other proteins as well. There are two simple
explanations for the differences in phenotype and differences
in protein profile. First, the levels of hsp90 vary from two- to
fivefold less in the amoebal variants. Since hsp90 can affect the
turnover of proteins that it interacts with (17, 26, 46, 60), it is
conceivable that the levels of other hsp90-associated proteins
would be affected differently depending on the levels of hsp90
present. This possibility is supported by the fact that both actin
(36, 48) and cyclophilins (68, 72) have been previously shown
to interact with hsp90. Possibly, hsp90 is involved in modifica-
tion of actin, since only actin migrating at a specific pI is at
lower levels in the variants than in the wild type and at least
three forms of actin are normally present in eukaryotic cells
(56, 67). Second, since multiple rounds of selection were car-
ried out, it is possible that secondary mutations were acquired
that are involved in some of the more subtle differences be-
tween the variants. Characterization of the other protein dif-
ferences and either reconstruction of the variants through mo-
lecular means or complementation analyses should help to
differentiate between these possibilities.
Although known inhibitors of hsp90 in mammalian cells had
no effect in amoebae, it is likely that this result is due to
differences between the amoebal and mammalian proteins,
transport of the inhibitors, or other aspects of amoebal phys-
iology. GA and the closely related compound HB are actino-
mycete fermentation products of the benzoquinone ansamycin
class (62). Ansamycin antibiotics such as GA and HB bind at
the ATP-binding site in the N-terminal domain of hsp90 and
disrupt the ATPase activity of hsp90, which is essential for its
chaperone activity in vivo (29, 51, 54, 58). Although RD has no
significant structural similarity to GA or HB, it also binds to
the N-terminal nucleotide-binding domain of hsp90 and inhib-
its the inherent ATPase activity of hsp90 (58). However, RD
shows a greater affinity for the nucleotide binding site than
does GA. Unlike GA, RD causes no significant conformational
changes (58). The binding site for NB lies within the C-termi-
nal region of hsp90 (40, 41). The second C-terminal ATP-
binding site is responsible for autophosphorylation of hsp90
(37). GA does not interfere with autophosphorylation of hsp90
and hence does not bind to the C-terminal ATP-binding site
(37). Since all of these inhibitors differ with respect to the
mechanism of hsp90 inhibition and specific chemical structure,
it is unlikely that nonspecific effects are responsible for the
observed phenotypic changes in macrophages. It is compelling
that hsp90 inhibitors produce a phagocytic defect in macro-
phages similar to that observed in amoebae. Furthermore,
hsp90 inhibitors also reduce bacterial survival and replication
in macrophages, as well as increase the numbers of mitochon-
dria. On the basis of these data, it is unlikely that the other
protein differences observed play as important a role in the
phenotypic characteristics of the amoebal variants as hsp90.
Overall, these studies demonstrate, for the first time, a role
for hsp90 in the interactions of phagocytic cells with bacteria.
This protein may influence the mechanisms of phagocytosis,
bactericidal activity, or a combination of these cellular pro-
cesses. Since there are direct links between the mechanism of
phagocytosis and subsequent intracellular events, it may be
difficult to differentiate between these possibilities. However,
careful examination of phagocytic and signal transduction
pathways in the variants and the wild type should provide
insight into the role of hsp90. Thus, the observation that hsp90
plays a role in early bacterium-phagocyte interactions is likely
to assist in elucidation of the cellular pathways involved.
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